Phenotypic and functional characterization of CAR-T cells with cytometry and live cell analysis

The use of advanced cell therapies is rapidly developing, particularly within the realms of cancer therapeutics. One key area that has accelerated advanced cell therapies has been the introduction of chimeric antigen receptor (CAR) T cells, which display specificity as well as lack of rejection from the patient. Explore how the use of both live-cell analysis and high-throughput screening by cytometry can add value when developing and characterizing T cell therapies, and how they can be applied to multiple cell types.